We are pleased to announce that Brent Barnes, CEO and Managing Director will be leading a non-deal roadshow in Australia this week. Mr Barnes and Ray Ridge, CFO, will be attending meetings with existing and new institutional investors as well as brokers and research analysts in Sydney, Melbourne and Adelaide. Click here to view the presentation
Today we released our financial report for year ending 30 June 2018.
Please click this link to hear the recording from the Quarterly Investor Call.
To dial into the call directly, please dial in 5 to 10 minutes prior to the call time and enter the Conference ID: 332129.
Dial in numbers are as follows:
Australian Toll Free: 1800 908 299
New Zealand callers: 0800 452 795
Other callers: +61 2 9007 8048
To pre-register for the call, please follow the link below. A unique pin number will be provided for use when dialling into the call, which will bypass the operator and provide immediate access to the event.
At the 14th Bioshares Biotech Summit, our CEO and MD was asked to address the topic, ‘The Investment Proposition – Does the Means Justify the End?’.
Click the link below to read the summarised presentation.
Please click the link to view the report
Click here is see our presentation at the 14th Bioshares Biotech Summit in Queenstown
We recently featured in a Bioshares article. Bioshares delivers independent investment research to investors on Australian biotech, pharma and healthcare companies . You can read the full article by clicking on the link bellow.
The APAS Independence, the product of Clever Culture Systems, the joint venture between LBT Innovations and Hettich Holding Beteiligungs- und Verwaltungs-GmbH (Germany), has won Silver at the Medical Design Excellence Awards.
The Medical Design Excellence Awards (MDEA) is the premier awards program for the medtech industry, running since 1998, dedicated to recognising significant achievements in medical product design and engineering that improves the quality of healthcare delivery and accessibility.